Tag Archives: Back

Primatene Mist Coming Back; Some Docs Concerned

Jason Shandell, president, Amphastar Pharmaceuticals Inc., Rancho Cucamonga, CA. Sandy Walsh, spokeswoman, FDA. FDA: “CDER Conversation: Safely Using the Newly Available OTC Asthma Inhaler Primatene Mist.” James Li, MD, PhD, professor of medicine, Mayo Clinic, Rochester, MN; former president, American Academy of Allergy, Asthma & Immunology. Dacia Morris, spokeswoman, American Thoracic Society, New York City.… Read More »